Community carriage of ESBL-producing Escherichia coli and Klebsiella pneumoniae: a cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates

被引:10
|
作者
Raffelsberger, Niclas [1 ,2 ]
Buczek, Dorota Julia [2 ]
Svendsen, Kristian [3 ]
Smabrekke, Lars [3 ]
Pontinen, Anna Kaarina H. [4 ,5 ]
Lohr, Iren [6 ]
Andreassen, Lotte Leonore Eivindsdatter [1 ]
Simonsen, Gunnar Skov [1 ,2 ]
Sundsfjord, Arnfinn [2 ,4 ]
Gravningen, Kirsten [1 ,7 ,8 ]
Samuelsen, Orjan [3 ,4 ]
机构
[1] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway
[2] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway
[3] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Tromso, Norway
[4] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway
[5] Univ Oslo, Dept Biostat, Oslo, Norway
[6] Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway
[7] Akershus Univ Hosp, Dept Microbiol & Infect Control, Nordbyhagen, Norway
[8] Univ Oslo, Inst Clin Med, Div Med & Lab Sci, Oslo, Norway
关键词
Escherichia coli; Klebsiella pneumoniae; extended-spectrum beta-lactamase; antimicrobial resistance; carriage; risk factors; general population; bacterial genomics; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; BLOOD-STREAM INFECTIONS; FECAL COLONIZATION; PREVALENCE; NORWAY; RESISTANCE; NATIONWIDE; EMERGENCE; MORTALITY; THERAPY;
D O I
10.1128/msphere.00025-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The global prevalence of infections caused by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) is increasing, and for Escherichia coli, observations indicate that this is partly driven by community-onset cases. The ESBL-E population structure in the community is scarcely described, and data on risk factors for carriage are conflicting. Here, we report the prevalence and population structure of fecal ESBL-producing E. coli and Klebsiella pneumoniae (ESBL-Ec/Kp) in a general adult population, examine risk factors, and compare carriage isolates with contemporary clinical isolates. Fecal samples obtained from 4,999 participants (54% women) >= 40 years in the seventh survey of the population-based Tromso Study, Norway (2015, 2016), were screened for ESBL-Ec/Kp. In addition, we included 118 ESBL-Ec clinical isolates from the Norwegian surveillance program in 2014. All isolates were whole-genome sequenced. Risk factors associated with carriage were analyzed using multivariable logistic regression. ESBL-Ec gastrointestinal carriage prevalence was 3.3% [95% confidence interval (CI) 2.8%-3.9%, no sex difference] and 0.08% (0.02%-0.20%) for ESBL-Kp. For ESBL-Ec, travel to Asia was the only independent risk factor (adjusted odds ratio 3.46, 95% CI 2.18-5.49). E. coli ST131 was most prevalent in both collections. However, the ST131 proportion was significantly lower in carriage (24%) versus clinical isolates (58%, P < 0.001). Carriage isolates were genetically more diverse with a higher proportion of phylogroup A (26%) than clinical isolates (5%, P < 0.001), indicating that ESBL gene acquisition occurs in a variety of E. coli lineages colonizing the gut. STs commonly related to extraintestinal infections were more frequent in clinical isolates also carrying a higher prevalence of antimicrobial resistance, which could indicate clone-associated pathogenicity. IMPORTANCE ESBL-Ec and ESBL-Kp are major pathogens in the global burden of antimicrobial resistance. However, there is a gap in knowledge concerning the bacterial population structure of human ESBL-Ec/Kp carriage isolates in the community. We have examined ESBL-Ec/Kp isolates from a population-based study and compared these to contemporary clinical isolates. The large genetic diversity of carriage isolates indicates frequent ESBL gene acquisition, while those causing invasive infections are more clone dependent and associated with a higher prevalence of antibiotic resistance. The knowledge of factors associated with ESBL carriage helps to identify patients at risk to combat the spread of resistant bacteria within the healthcare system. Particularly, previous travel to Asia stands out as a major risk factor for carriage and should be considered in selecting empirical antibiotic treatment in critically ill patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Human carriage of ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae in relation to the consumption of raw or undercooked vegetables, fruits, and fresh herbs
    Meijs, A. P.
    Rozwandowicz, M.
    Hengeveld, P. D.
    Dierikx, C. M.
    de Greeff, S. C.
    van Duijkeren, E.
    van Dissel, J. T.
    Tamber, Sandeep
    MICROBIOLOGY SPECTRUM, 2024, 12 (02):
  • [32] ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015
    Birgy, Andr
    Levy, Corinne
    Bidet, Philippe
    Thollot, Franck
    Derkx, Veronique
    Bechet, Stephane
    Mariani-Kurkdjian, Patricia
    Cohen, Robert
    Bonacorsi, Stephane
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (10) : 2949 - 2956
  • [33] Dietary Factors of blaNDM Carriage in Health Community Population: A Cross-Sectional Study
    Hu, Shuangfang
    Lv, Ziquan
    Xiang, Qiumei
    Wang, Yang
    Shen, Jianzhong
    Ke, Yuebin
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (11)
  • [34] Risk factors for fecal carriage of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in the community
    Azap, Oezlem Kurt
    Arslan, Hande
    Karaman, Sedef Oe.
    Togan, Turhan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2007, 37 (01) : 31 - 38
  • [35] IDENTIFICATION OF VIRULENCE FACTORS AMONG ESBL-PRODUCING ESCHERICHIA COLI CLINICAL ISOLATES FROM GAZA STRIP, PALESTINE
    Tayh, Ghassan
    Nagarjuna, Daram
    Ben Sallem, Rym
    Verma, Vivek
    Ben Yahia, Houssem
    Gharsa, Haythem
    Yadav, Manisha
    Ben Slama, Karim
    JOURNAL OF MICROBIOLOGY BIOTECHNOLOGY AND FOOD SCIENCES, 2021, 11 (03):
  • [36] Distribution of ESBL producing Uropathogenic Escherichia coli and carriage of selected beta-lactamase genes in Hospital and community isolates in west of Iran
    Mohajeri, Parviz
    Rostami, Zhila
    Farahani, Abbas
    Norozi, Baharak
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 7 (05) : 219 - 222
  • [37] Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality
    Taysi, Muhammet Ridvan
    Ocal, Duygu
    Senturk, Gonul Cicek
    Caliskan, Elif
    Celik, Bahar
    Sencan, Irfan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, : 1540 - 1546
  • [38] Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study
    Larramendy, Stephanie
    Gaultier, Aurelie
    Fournier, Jean-Pascal
    Caillon, Jocelyne
    Moret, Leila
    Beaudeau, Francois
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (03) : 789 - 795
  • [39] Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality
    Taysi, Muhammet Ridvan
    Ocal, Duygu
    Sentuerk, Gonul Cicek
    Caliskan, Elif
    Celik, Bahar
    Sencan, Irfan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (07) : 1540 - 1546
  • [40] Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study
    Hristea, Adriana
    Olaru, Ioana D.
    Adams-Sapper, Sheila
    Riley, Lee W.
    INFECTIOUS DISEASES, 2015, 47 (01) : 46 - 51